14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.62 $2.30 Wednesday, 24th Apr 2024 CTMX stock ended at $1.63. This is 2.98% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.94% from a day low at $1.62 to a day high of $1.70.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Dec 04, 2020 $7.30 $7.46 $7.27 $7.40 425 260
Dec 03, 2020 $7.43 $7.50 $7.13 $7.27 453 867
Dec 02, 2020 $7.52 $7.52 $7.32 $7.42 616 107
Dec 01, 2020 $7.61 $7.79 $7.47 $7.53 447 907
Nov 30, 2020 $7.37 $7.66 $7.37 $7.52 500 853
Nov 27, 2020 $7.37 $7.47 $7.30 $7.42 187 985
Nov 25, 2020 $7.31 $7.43 $7.08 $7.35 507 731
Nov 24, 2020 $7.36 $7.55 $7.11 $7.38 735 792
Nov 23, 2020 $7.36 $7.52 $7.30 $7.32 262 051
Nov 20, 2020 $7.36 $7.40 $7.20 $7.32 191 896
Nov 19, 2020 $7.34 $7.60 $7.34 $7.41 199 358
Nov 18, 2020 $7.36 $7.60 $7.27 $7.32 277 619
Nov 17, 2020 $7.25 $7.42 $7.13 $7.38 236 237
Nov 16, 2020 $7.50 $7.52 $7.13 $7.33 348 864
Nov 13, 2020 $7.70 $7.78 $7.38 $7.40 237 614
Nov 12, 2020 $7.53 $7.85 $7.31 $7.65 538 553
Nov 11, 2020 $7.44 $7.58 $7.17 $7.52 396 156
Nov 10, 2020 $6.92 $7.49 $6.84 $7.47 399 522
Nov 09, 2020 $7.27 $7.40 $6.82 $6.84 407 667
Nov 06, 2020 $7.17 $7.23 $6.82 $7.02 332 884
Nov 05, 2020 $7.08 $7.14 $6.76 $7.07 360 961
Nov 04, 2020 $6.66 $7.15 $6.66 $7.07 469 093
Nov 03, 2020 $6.61 $6.79 $6.45 $6.73 269 893
Nov 02, 2020 $6.68 $6.77 $6.40 $6.56 425 745
Oct 30, 2020 $6.76 $6.78 $6.52 $6.62 313 044
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT